Activation of the VEGF-A/ERK/PLA2 Axis Mediates Early Retinal Endothelial Cell Damage Induced by High Glucose: New Insight from an In Vitro Model of Diabetic Retinopathy.
Activation of the VEGF-A/ERK/PLA2 Axis Mediates Early Retinal Endothelial Cell Damage Induced by High Glucose: New Insight from an In Vitro Model of Diabetic Retinopathy.
复制标题
VEGF-A/ERK/PLA 2轴的激活介导高糖诱导的早期视网膜内皮细胞损伤:来自糖尿病视网膜病变体外模型的新见解
DOI:
10.3390/ijms21207528
复制
发表时间:
2020-10-13
影响因子:
5.6
通讯作者:
Bucolo C
中科院分区:
文献类型:
--
作者:
Giurdanella G;Lupo G;Gennuso F;Conti F;Furno DL;Mannino G;Anfuso CD;Drago F;Salomone S;Bucolo C
Early blood retinal barrier (BRB) dysfunction induced by hyperglycemia was related to increased pro-inflammatory activity of phospholipase A2 (PLA2) and the upregulation of vascular endothelial growth factor A (VEGF-A). Here, we tested the role of VEGF-A in high glucose (HG)-induced damage of human retinal endothelial cells (HRECs) mediated by Ca++-dependent (cPLA2) and Ca++-independent (iPLA2) PLA2s. HRECs were treated with normal glucose (5 mM, NG) or high glucose (25 mM, HG) for 48 h with or without the VEGF-trap Aflibercept (Afl, 40 µg/mL), the cPLA2 inhibitor arachidonoyl trifluoromethyl ketone (AACOCF3; 15 µM), the iPLA2 inhibitor bromoenol lactone (BEL; 5 µM), or VEGF-A (80 ng/mL). Both Afl and AACOCF3 prevented HG-induced damage (MTT and LDH release), impairment of angiogenic potential (tube-formation), and expression of VEGF-A mRNA. Furthermore, Afl counteracted HG-induced increase of phospho-ERK and phospho-cPLA2 (immunoblot). VEGF-A in HG-medium increased glucose toxicity, through upregulation of phospho-ERK, phospho-cPLA2, and iPLA2 (about 55%, 45%, and 50%, respectively); immunocytochemistry confirmed the activation of these proteins. cPLA2 knockdown by siRNA entirely prevented cell damage induced by HG or by HG plus VEGF-A, while iPLA2 knockdown produced a milder protective effect. These data indicate that VEGF-A mediates the early glucose-induced damage in retinal endothelium through the involvement of ERK1/2/PLA2 axis activation.
登录
查看更多内容
影响因子:
4.5
作者:
Gong Y;Jin X;Wang QS;Wei SH;Hou BK;Li HY;Zhang MN;Li ZH
通讯作者:
Li ZH
影响因子:
4.1
作者:
Boslem, Ebru;MacIntosh, Gemma;Biden, Trevor J.
通讯作者:
Biden, Trevor J.
DOI:
10.1016/s1054-3589(08)61011-x
发表时间:
1995-01-01
期刊:
Advances in pharmacology (San Diego, Calif.)
影响因子:
--
作者:
Glaser, K B
通讯作者:
Glaser, K B
影响因子:
3.3
作者:
Askarova, S.;Yang, X.;Sheng, W.;Sun, G. Y.;Lee, J. C-M
通讯作者:
Lee, J. C-M
影响因子:
3.1
作者:
Anfuso, Carmelina Daniela;Giurdanella, Giovanni;Alberghina, Mario
通讯作者:
Alberghina, Mario